Joshua Hexter - 17 Mar 2026 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
COO & CBO
Signature
/s/ Joshua Hexter
Issuer symbol
ORMP
Transactions as of
17 Mar 2026
Net transactions value
$0
Form type
4
Filing time
18 Mar 2026, 17:46:15 UTC
Previous filing
29 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hexter Joshua COO & CBO 1185 AVENUE OF THE AMERICAS, THIRD FLOOR, NEW YORK /s/ Joshua Hexter 18 Mar 2026 0001573235

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +95,889 +9% $0.000000* 1,160,384 17 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs"). The RSUs will vest ratably in 8 quarterly installments beginning April 1, 2026. Each RSU represents the right to receive one share of common stock, par value $0.012 per share, of the Issuer.